November 18, 2020
Rose
Moderna is the second company to report preliminary results from a large trial testing a vaccine. But there are still months to go before it will be widely available to the public.
from Health https://ift.tt/2UyqU4W
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment